New cancer clinical trial: Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive

Published on: December 31, 2018 at 12:00PM
Condition:   Non Small Cell Lung Cancer
Intervention:   Drug: Osimertinib
Sponsor:   Fundación Grupo Español de Cáncer de Pulmón
Not yet recruiting
http://bit.ly/2LJf4zm